• Nutrition Research and Practice
• /
• v.10 no.5
• /
• pp.507-515
• /
• 2016

BACKGROUND/OBJECTIVES: This study was designed to investigate whether Gynura procumbens extract (GPE) can improve insulin sensitivity and suppress hepatic glucose production in an animal model of type 2 diabetes. MATERIALS/METHODS: C57BL/Ksj-db/db mice were divided into 3 groups, a regular diet (control), GPE, and rosiglitazone groups (0.005 g/100 g diet) and fed for 6 weeks. RESULTS: Mice supplemented with GPE showed significantly lower blood levels of glucose and glycosylated hemoglobin than diabetic control mice. Glucose and insulin tolerance test also showed the positive effect of GPE on increasing insulin sensitivity. The homeostatic index of insulin resistance was significantly lower in mice supplemented with GPE than in the diabetic control mice. In the skeletal muscle, the expression of phosphorylated AMP-activated protein kinase, pAkt substrate of 160 kDa, and PM-glucose transporter type 4 increased in mice supplemented with GPE when compared to that of the diabetic control mice. GPE also decreased the expression of glucose-6-phosphatase and phosphoenolpyruvate carboxykinase in the liver. CONCLUSIONS: These findings demonstrate that GPE might improve insulin sensitivity and inhibit gluconeogenesis in the liver.

• The Journal of Korean Medicine
• /
• v.31 no.4
• /
• pp.20-37
• /
• 2010

Objective: This study was performed to investigate the effect of Yagwan-cheunghyeoltang (YCT) on insulin secretion in RIN-m5F cells. Methods: After treatment with various concentrations of YCT to RIN-m5F cells, cell viability, free radical-scavenging activity, SOD activity, and insulin secretion were measured. Additionally, insulin-related gene expressions were measured using real-time RT-PCR. Results: 1. YCT didn't show any influence on RIN-m5F cells viability. 2. YCT showed free radical-scavenging activity by 16% at $100{\mu}g/m{\ell}$ of concentration. 3. YCT showed enhancement of SOD activity by 60% at $100{\mu}g/m{\ell}$ of concentration. 4. YCT significantly increased insulin secretion in RIN-m5F cells in a dose-dependent manner. 5. YCT up-regulated INS-1, INS-2, IRS-1, IRS-2 and IRS-3 mRNA expressions compared to the control group. 6. YCT down-regulated INS-R, GCK, GLP-1R and GLP-2R mRNA expressions compared to the control group. Conclusion: YCT has pharmaceutical properties enhancing insulin production and controlling glucose-associated metabolism, and could be a candidate for drug development after further research.

• Journal of Nutrition and Health
• /
• v.26 no.1
• /
• pp.34-46
• /
• 1993

This study was performed to investigate the interrelationship between fasting serum insulin, eating behaviour, daily energy intake and the fatness in obese and non-obese women. The possibility of fasting serum insulin as potential predictive factor for eating behaviour and daily energy intake was also investigated. The results are as follows: 1) In obese women ; Subjects with higher fasting serum insulin were associated with higher speed of eating and shorter meal duration time. No association could be found between daily energy intake or the degree of obesity and fasting serum insulin. There was a significant positive correlation between obesity, daily energy intake and speed of eating. Obesity, daily energy intake were negatively related to meal duration time. Subjects with a rapid speed of eating were apt to overeat during eating behaviour experiment. Our findings suggested that a rapid speed of eating is a contributing factor to the development of obesity in obese women. 2) In non-obese women ; While subjects with higher insulin level were apt to overeat, we could not find any relation between overeating and daily energy intake. There was no correlation between eating speed and daily energy intake, but a significant positive correlation was found between meal duration time and daily energy intake. The degree of fatness was increased with the lower daily energy expenditure per body weight, or the higher waist hip girth ratio, fasting serum insulin and daily energy intake.

• Journal of Nutrition and Health
• /
• v.23 no.4
• /
• pp.270-278
• /
• 1990

This study was an attempt to investigate the usefulness of maltitol as an alternative sweetener. The acute effects of oral ingestion of 50g of maltitol or glucose on blood glucose and insulin levels following test dose were investigated by using five healthy normal subjects and ten diabetic patients. The data demonstrated marked differences between the utilization of maltitol and of glucose in both groups. Blood glucose and insulin responses to glucose were significantly greater than to maltitol in normal subjects(p<0.05). In diabetic patients, the peaks of the mean increment in blood glucose concentration after glucose and maltitol were reached at 60 minutes with mean values of 135mg/dl and 49mg/dl, respectively, and these differences were statistically significant(p<0.001). As for blood insulin responses in diabetic patients, the peak of the mean increment after glucose was 25.03$\mu$U/ml at 120 minutes. In contrast insulin responses to maltitol were significantly lower than to glucose(p<0.05), and the peak value was 7.98$\mu$u/ml at 60min. From these results it can be concluded that ingestion of maltitol resulted in significantly lower blood glucose and insulin increments than did glucose in both normal and diabetic patients.

• Korean Journal of Veterinary Research
• /
• v.38 no.2
• /
• pp.239-245
• /
• 1998

The distributions and relative frequencies of insulin-, glucagon-, and somatostatin-immunoreactive cells in the pancreas of the duck(Anas platyrhynchos platyrhyncos, Linne) were investigated immunohistochemically on 23 days of incubation, at hatching, 1 week, 2 weeks, 3 weeks, 5 weeks, 6 weeks, 7 weeks, 9 weeks, 10 weeks, and 32 weeks after hatching. In the duck pancreas on 23 days of incubation and at hatching, mammalian type islets(mixed type) were only observed, thereafter three type's islets(mamalian, A and B type's islets) were identified. Insulin-immunoreactive cells were detected in central region of the islets, while glucagon- and somatostatin-immunoreactive cells were detected in marginal region of light(B type) or mammalian type islets, and in central region of dark islets(A type). Insulin-, and somatostatin-immunoreactive cells were also detected in the exocrine regions. In this region the insulin-immunoreactive cells were detected from 23 days of incubation to 6 weeks, however not detected after 7 weeks. At hatching the relative numbers of somatostatin-immunoreactive cells were more frequent than those of other groups, and then decreased with ages.

• Journal of the korean academy of Pediatric Dentistry
• /
• v.31 no.3
• /
• pp.481-485
• /
• 2004

Rabson-Mendenhall syndrome(RMS) is first characterized in 1955 by Rabson and Mendenhall. RMS is a rare autosomal recessive variant with insulin resistance. This is due to insulin receptor mutations or other target-cell defects in insulin action. General findings include acanthosis nigricans, hypertrichosis, onychauxis, growth retardation, precocious puberty, genital enlargement, protuberant abdomen and xerotic skin. Characteristic oral and maxillofacial findings include dental dysplasia, coarse facial skin, prognathic jaw and fissured tongue. In this case report, dental characteristics of a 4-year old boy with Rabson-Mendenhall syndrome are described.

• Proceedings of the Korean Society of Applied Pharmacology
• /
• 1998.05a
• /
• pp.1-4
• /
• 1998

Impaired insulin action in Type 2 diabetes is thought to lead to hyperglycemia, with both environmental and complex genetic factors playing key roles. Although the primary lesion in Type 2 diabetes is unknown, a number of studies suggest that metabolic defects in the liver, skeletal muscle and fat, and pancreatic ${\beta}$-cells contribute to the disease. These metabolic abnormalities are characterized by the overproduction of hepatic glucose, impaired insulin secretion, and peripheral insulin resistance. In current pharmacological treatment of Type 2 diabetes, sulfonylurea (SU) drugs have mainly been used as oral hypoglycemic drugs to stimulate endogenous insulin secretion from ${\beta}$ cells. SU drugs, however, sometimes aggravate the disease by causing fatigue of the pancreatic ${\beta}$ cells, which leads to reduced drug efficacy after long-term treatment. This class of drugs also leads to enhanced obesity arising from the stimulation of endogenous insulin secretion in obese Type 2 diabetic patients, plus an increased incidence of SU-induced hypoglycemia. Since 1980, a major challenge has been made by us to develop a potential pharmacological therapy for the treatment of insulin resistance in peripheral tissues and/or suppression of abnormal hepatic glucose production in Type 2 diabetic patients. Such a drug would be expected to have fewer side effects and retain long-term efficacy.

• Journal of Korean Academy of Fundamentals of Nursing
• /
• v.11 no.1
• /
• pp.67-73
• /
• 2004

Purpose: The purpose of this study was to investigate the knowledge of diabetes and insulin use in patients with type 2 diabetes. Method: Participants (139) were recruited from the endocrinology outpatient department of a tertiary care hospital in an urban city. Knowledge of diabetes knowledge was measured by a brief diabetes knowledge test which had two components: a 14-item general test and a 9-item insulin-use subscale. Result: The average scores for knowledge of diabetes and insulin were 62.4 and 41.8 respectively. Scores were lower for items on the definition of glycosylated hemoglobin, diabetic diet, signs of ketoacidosis, and insulin reaction compared to other items. Knowledge scores were significantly lower for older participants, those who had lower levels of education, those who did not have a spouse, those who did not have a job, those who were not being treated with insulin, and those who tested their blood glucose less than 3 times a day. Conclusion: Definition of glycosylated hemoglobin, diabetic diet, signs of ketoacidosis, and insulin reaction should be included in education for patients with type 2 diabetes. Special education programs should be developed for elderly people, those with low levels of education those without a spouse, or without a job, or who are not being treated with insulin.

• Journal of mucopolysaccharidosis and rare diseases
• /
• v.2 no.2
• /
• pp.50-51
• /
• 2016

Combining basal insulin therapy with a glucagon-like peptide-1 receptor agonist (GLP-1 RA) has clear clinical advantages, and is supported by the latest EASD/ADA position statement (1). IDegLira is a once-daily combination of the basal insulin, degludec, and the GLP-1RA, liraglutide, in one pen. The DUAL phase 3 clinical trial program provides important evidence about the efficacy and safety of IDegLira in three different populations of patients with type 2 diabetes (T2D): insulin naïve subjects uncontrolled on oral antidiabetic drugs (OADs), subjects uncontrolled on OAD(s) and a GLP-1 RA, and subjects uncontrolled on OAD(s) and basal insulin. Treatment with IDegLira reduced mean HbA1c to below the EASD/ADA treatment target of 7.0% in all five trials. The mean reduction of HbA1c from baseline ranged from 1.3% and 1.9%. IDegLira resulted in weight loss for subjects uncontrolled on basal insulin, was weight neutral for subjects on OADs and weight gain was minimal (2 kg) for subjects previously treated with a GLP-1 RA. Rates of hypoglycaemia were low across all the trials, particularly considering the level of glycaemic control achieved.

• Journal of Korean Academy of Fundamentals of Nursing
• /
• v.20 no.1
• /
• pp.27-36
• /
• 2013

Purpose: Self-care behavior is a key dimension of healthcare quality among elderlys with diabetes mellitus. The purpose of this study was to identify factors associated with self-care behaviors related to insulin therapy among elders with diabetes mellitus. Methods: The research was a cross-sectional, descriptive design using questionnaires. The participants were 147 older adult patients with diabetes mellitus receiving insulin therapy. Data were analyzed using descriptive statistics, t-test, ANOVA and multiple regression with SPSS statistics 19.0 program. Results: Participants' self-care behaviors related to insulin therapy were not adequate. Stepwise multiple regression analysis for self-care behaviors related to insulin therapy revealed that the most powerful predictor was self-efficacy. Self-efficacy, family support and frequency of blood sugar test explained 54.4% of the variance in self-care behaviors related to insulin therapy. Conclusion: The results indicate a need to promote self-efficacy, family support and frequency of blood sugar testing with these participants. In addition, strategies to improve self-care behaviors among elderly patients should be considered by health professionals, family members and the elderly patients themselves.